期刊文献+

HIV-1潜伏感染的细胞模型

Cell models of HIV-1 latency
原文传递
导出
摘要 人类免疫缺陷病毒1型(human immunodeficiency virus type 1,HIV-1)感染导致艾滋病(acquired immunodeficiency syndrome,AIDS),严重危害人类健康.抗逆转录病毒疗法(antiretroviral therapy,ART)可高效抑制HIV-1复制,但无法治愈艾滋病,主要原因是HIV-1可在机体建立潜伏感染,形成稳定的病毒储存库.这些含有沉默的整合病毒的储存库细胞在ART治疗的个体中频率极低,人们难以对其直接分离而进行研究.因此,为研究HIV-1潜伏感染的机制及靶向治疗病毒储存库的方法,建立HIV-1潜伏感染的细胞模型非常重要.本文总结概述了多种常用的HIV-1潜伏感染的细胞模型及其应用,并分析了这些模型各自的优点和局限性,可为进一步深入研究HIV-1潜伏感染和艾滋病功能性治愈提供有效的工具参考和理论依据. Human immunodeficiency virus type 1,(HIV-1)infection leads to acquired immunodeficiency syndrome(AIDS),which seriously harms human health.Antiretroviral therapy(ART)can effectively suppress HIV-1 replication but cannot cure AIDS,mainly because HIV-1 establishes latent infection and forms a stable viral latent reservoir in HIV-1-infected individuals.These latently infected cells with silent integrated proviruses are extremely rare in ART-treated individuals;therefore it is difficult to isolate them directly for research.In order to study the mechanism of latent HIV-1 infection and strategies targeting the viral reservoirs,it is critical to generate cell models for HIV-1 latent infection.Here we review a variety of classical in vitro HIV-1 latency models and their applications,and analyze the advantages and limitations of these models.This review provides an effective reference and theoretical basis for further in-depth study of HIV-1 latency and AIDS functional cure.
作者 彭雯 邓凯 PENG Wen;DENG Kai(Institute of Human Virology,Key Laboratory of Tropical Disease Control of Ministry of Education,Zhongshan School of Medicine,Sun Yat-sen University,Guangzhou 510080,China)
出处 《中国科学:生命科学》 CSCD 北大核心 2020年第10期1025-1031,共7页 Scientia Sinica(Vitae)
基金 国家自然科学基金(批准号:81672024) 广东省自然科学基金(批准号:2017A030306005)资助。
关键词 HIV-1 潜伏感染 病毒储存库 细胞模型 HIV-1 latent infection viral latent reservoir cell model
  • 相关文献

参考文献3

二级参考文献33

  • 1Palmer S, Maldarelli F, Wiegand A,et al. Low-level viremia per- sists for at least 7 years in patients on suppressive antiretroviral therapy[J]. Proc Natl Acad Sci USA, 2008,105 (10), 3879-3884.
  • 2Palmer S, Josefsson L, Coffin JM. HIV reservoirs and the possi- bility of a cure for HIV infection[J]. J Intern Med, 2011,270 (6) :550-560.
  • 3Finzi D, Hermankova M, Pierson T,etal. Identification of a res- ervoir for HIV] in patients on highly active antiretroviral therapy [J]. Science, 1997,278(5341) : 1295-1300.
  • 4Wong ]K, Hezareh M, Gtinthard HF,et al. Recovery of replica- tion-competent HIV despite prolonged suppression of plasma vire- mia[J].Science,1997,278(5341) :1291-1295.
  • 5Chun TW, Carruth L, Finzi D,etal. Quantification of latent tis- sue reservoirs and total body viral load in HIV-1 infection[J]. Nature, 1997,387(6629) :183-188.
  • 6Schorder AR, Shinn P, Chen H, etal. HIV1 intergration in the human genome favors active genes and local hotspots[J]. Cell, 2002,110 (4) : 521-529.
  • 7Williams SA, Chen LF, Kwon H, et al. NF-kappaB p50 pro- motes HIV latency through HDAC recruitment and repression of transcriptional initiation [J]. EMBO J, 2006, 25 ( 1 ) : 139- 149.
  • 8Kao SY, Calman AF, Luciw PA, etal. Anti-termination of tran- scription within the long terminal repeat of HIV-1 by tat gene product[J]. Nature, 1987, 330:489-493.
  • 9Yukl S, Pillai S, Li P, et al. Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation ac- tivitv[J]. Virology, 2009. 387,98-108.
  • 10Van Lint C, Emiliani S, Ott M,et al. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation [ J ]. EMBO J, 1996, 15 ( 5 ) : 1112-1120. PMID:8605881.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部